Background: The purpose of this study was to investigate the prevalence of osteosarcopenia in the over 60-year-old community and to evaluate whether osteosarcopenia is associated with disability, frailty and depression.
Methods: This study was performed using the baseline data of Namgaram-2, which was developed to study the relationship between the prevalence of musculoskeletal disorders and activity limitations in the elderly in rural areas. Among the 1010 surveyed subjects, 885 study subjects who were 60 years or older and had all necessary tests performed were selected. The Kaigo-Yobo checklist was completed for diagnosis of frailty and the degree of disability in everyday life was evaluated by World Health Organization Disability Assessment Schedule (WHODAS). To understand the symptoms of depression in the elderly, the Geriatric Depression Scale-Short Form-Korean (GDSSF-K) was used. The Asian Working Group for Sarcopenia (AWGS 2019) were applied in this study. Sarcopenia was defined as SMI less than 7.0 kg/m2 in men and less than 5.4 kg/m2 in women. The maximum grip strength was used as a reference level, for men below 28 kg and for women below 18 kg. Osteopenia was measured using data from dual energy X-ray absorptiometry (DEXA) and osteopenia was diagnosed when the T-score was less than -1.0.
The study subjects were divided into four groups: the normal group, in which both sarcopenia and osteopenia were undiagnosed, osteopenia only, sarcopenia only and the osteosarcopenia group, which was diagnosed with both sarcopenia and osteopenia.
Results: Of the 885 subjects over 60 years old evaluated, the normal group comprised 34.0%, the only osteopenia group 33.7%, the only sarcopenia group 13.1%, and the osteosarcopenia group 19.2%. WHODAS, Kaigo-Yobo, and GDSSF scores were statistically significantly higher in the osteosarcopenia group compared the other groups.
Conclusions: Osteosarcopenia is a relatively common disease group in the elderly community that may cause deterioration of health outcomes. Therefore, when evaluating osteopenia or sarcopenia in the elderly, management of those in both disease groups should occur together.
Figure 1

Figure 2
Loading...
On 11 Jan, 2021
On 10 Jan, 2021
Received 22 Dec, 2020
Invitations sent on 15 Dec, 2020
On 15 Dec, 2020
On 14 Dec, 2020
On 14 Dec, 2020
On 14 Dec, 2020
Posted 05 Nov, 2020
On 25 Nov, 2020
Received 15 Nov, 2020
On 05 Nov, 2020
Invitations sent on 05 Nov, 2020
On 05 Nov, 2020
Received 05 Nov, 2020
On 29 Oct, 2020
On 29 Oct, 2020
On 29 Oct, 2020
On 13 Oct, 2020
Received 05 Oct, 2020
On 27 Sep, 2020
On 03 Sep, 2020
Received 03 Sep, 2020
Invitations sent on 17 Aug, 2020
On 21 May, 2020
On 20 May, 2020
On 20 May, 2020
On 11 Jan, 2021
On 10 Jan, 2021
Received 22 Dec, 2020
Invitations sent on 15 Dec, 2020
On 15 Dec, 2020
On 14 Dec, 2020
On 14 Dec, 2020
On 14 Dec, 2020
Posted 05 Nov, 2020
On 25 Nov, 2020
Received 15 Nov, 2020
On 05 Nov, 2020
Invitations sent on 05 Nov, 2020
On 05 Nov, 2020
Received 05 Nov, 2020
On 29 Oct, 2020
On 29 Oct, 2020
On 29 Oct, 2020
On 13 Oct, 2020
Received 05 Oct, 2020
On 27 Sep, 2020
On 03 Sep, 2020
Received 03 Sep, 2020
Invitations sent on 17 Aug, 2020
On 21 May, 2020
On 20 May, 2020
On 20 May, 2020
Background: The purpose of this study was to investigate the prevalence of osteosarcopenia in the over 60-year-old community and to evaluate whether osteosarcopenia is associated with disability, frailty and depression.
Methods: This study was performed using the baseline data of Namgaram-2, which was developed to study the relationship between the prevalence of musculoskeletal disorders and activity limitations in the elderly in rural areas. Among the 1010 surveyed subjects, 885 study subjects who were 60 years or older and had all necessary tests performed were selected. The Kaigo-Yobo checklist was completed for diagnosis of frailty and the degree of disability in everyday life was evaluated by World Health Organization Disability Assessment Schedule (WHODAS). To understand the symptoms of depression in the elderly, the Geriatric Depression Scale-Short Form-Korean (GDSSF-K) was used. The Asian Working Group for Sarcopenia (AWGS 2019) were applied in this study. Sarcopenia was defined as SMI less than 7.0 kg/m2 in men and less than 5.4 kg/m2 in women. The maximum grip strength was used as a reference level, for men below 28 kg and for women below 18 kg. Osteopenia was measured using data from dual energy X-ray absorptiometry (DEXA) and osteopenia was diagnosed when the T-score was less than -1.0.
The study subjects were divided into four groups: the normal group, in which both sarcopenia and osteopenia were undiagnosed, osteopenia only, sarcopenia only and the osteosarcopenia group, which was diagnosed with both sarcopenia and osteopenia.
Results: Of the 885 subjects over 60 years old evaluated, the normal group comprised 34.0%, the only osteopenia group 33.7%, the only sarcopenia group 13.1%, and the osteosarcopenia group 19.2%. WHODAS, Kaigo-Yobo, and GDSSF scores were statistically significantly higher in the osteosarcopenia group compared the other groups.
Conclusions: Osteosarcopenia is a relatively common disease group in the elderly community that may cause deterioration of health outcomes. Therefore, when evaluating osteopenia or sarcopenia in the elderly, management of those in both disease groups should occur together.
Figure 1

Figure 2
Loading...